Sanofi has announced that it will lower the list price of its insulin drug, Lantus, by 78 percent and will set a $35 cap on out-of-pocket costs for all patients.
The price change and cap will go into effect starting January 1, 2024. They follow a series of moves made last year to lower the price of diabetes medicine, including the launch of an unbranded version of Lantus and a $35 cap for uninsured patients.
Yet, Olivier Bogillot, head of U.S. general medicines at Sanofi, said "the health system was unable to take advantage of it due to its inherent structural challenges."
“Sanofi believes that no one should struggle to pay for their insulin and we are proud of our continued actions to improve access and affordability for millions of patients for many years," he said. "Our decision to cut the list price of our lead insulin needs to be coupled with broader change to the overall system to actually drive savings for patients at the pharmacy counter.”
Sanofi will also cut the price of short-acting Apidra by 70 percent.
Loy Gordon, owner of Neir's Tavern, joined Cheddar News to discuss how he saved the establishment three times and why he did so. Gordon also showed Cheddar News some specialty drinks that patrons can enjoy.
To celebrate Black-Owned Business Month, Cheddar News visited Neir's Tavern in Queens, one of the city's oldest taverns where the Martin Scorsese film "Goodfellas" was filmed. Loy Gordon, the bar's owner, discussed the history behind the establishment.
WeWork is warning there’s “substantial doubt” about its ability to stay in business over the next year because of its financial losses and its need for cash, among other factors.
